TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Endocrine-Related Cancer

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/ERC-15-0383PMID 26647384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.

  2015cited by this paper
• Epithelial ovarian cancer experimental models

  2014cited by this paper
• Epithelial-Mesenchymal Transition Associates with Maintenance of Stemness in Spheroid-Derived Stem-Like Colon Cancer Cells

  2013cited by this paper
• SNAI1 overexpression induces stemness and promotes ovarian cancer cell invasion and metastasis.

  2012cited by this paper
• Targeting the TGFβ signalling pathway in disease

  2012cited by this paper
• Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.

  2012cited by this paper
• EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

  2012cited by this paper
• BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation

  2012influential reference
• Targeting the TGFβ signalling pathway in disease

  2012cited by this paper
• Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer

  2012cited by this paper
• Epithelial–Mesenchymal Transition in Ovarian Carcinoma

  2012cited by this paper
• Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer.

  2012cited by this paper
• Early versus delayed treatment of relapsed ovarian cancer.

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions

  2010cited by this paper
• Epithelial-mesenchymal transition in ovarian cancer.

  2010influential reference
• TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.

  2010cited by this paper
• Ovarian cancer development and metastasis.

  2010cited by this paper
• Expression and localization of e-cadherin in epithelial ovarian cancer.

  2010cited by this paper
• Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression

  2010influential reference
• The basics of epithelial-mesenchymal transition.

  2009cited by this paper
• The biology of ovarian cancer: new opportunities for translation

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

  2009influential reference
• Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression

  2009cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.

  2008cited by this paper
• Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?

  2008cited by this paper
• p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.

  2008influential reference
• The epithelial-mesenchymal transition generates cells with properties of stem cells.

  2008cited by this paper
• Transforming Growth Factor-β1, Transforming Growth Factor-β2, and Transforming Growth Factor-β3 Enhance Ovarian Cancer Metastatic Potential by Inducing a Smad3-Dependent Epithelial-to-Mesenchymal Transition

  2008cited by this paper
• Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm

  2007cited by this paper
• Large- and small-molecule inhibitors of transforming growth factor-beta signaling.

  2006cited by this paper
• Transforming growth factor-beta in cancer and metastasis.

  2006cited by this paper
• Clinical Evaluation of E-cadherin Expression and its Regulation Mechanism in Epithelial Ovarian Cancer

  2006cited by this paper
• Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients

  2006cited by this paper
• Transforming growth factor-β in cancer and metastasis

  2006cited by this paper
• Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level.

  2005cited by this paper
• Regulation of cadherin-mediated adhesion in morphogenesis

  2005cited by this paper
• TGF-beta and epithelial-to-mesenchymal transitions.

  2005cited by this paper
• TGF-β and epithelial-to-mesenchymal transitions

  2005cited by this paper
• Immunohistochemical patterns for α- and β-catenin, E- and N-cadherin expression in ovarian epithelial tumors

  2004cited by this paper
• Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.

  2004cited by this paper
• Inhibition of the antiproliferative effect of TGFβ by EGF in primary human ovarian cancer cells

  2003cited by this paper
• SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

  2002cited by this paper
• TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells.

  2002cited by this paper
• Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells.

  2000cited by this paper
• Cancer of the ovary.

  1994cited by this paper
• Cancer of the ovary.

  1993cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy

  2026cites this paper
• An altered proteome in ovarian cancer stem-like cells: profiling of the mDivi-1 induced proteome and its clinical significance.

  2025cites this paper
• Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis

  2025cites this paper
• Construction Of Multicellular Tumor-On-A-Chip Models for Ovarian Cancer Research

  2025cites this paper
• NFIC suppressed the epithelial ovarian cancer via modulating the balance of PTEN/TGFβ1/EGR1/BRD4 and SP1/EZH2 induced Inhibition of TBX2/MMPs signaling

  2025cites this paper
• A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities

  2025cites this paper
• Horizontal blocking of metastatic growth factors signaling by low molecular weight heparin derivative to control ovarian cancer progression.

  2025cites this paper
• EMMPRIN promotes spheroid organization and metastatic formation: comparison between monolayers and spheroids of CT26 colon carcinoma cells

  2024cites this paper
• How important is EMT for cancer metastasis?

  2024cites this paper
• Insights into high-grade serous carcinoma pathobiology using three-dimensional culture model systems

  2023cites this paper
• The Mechanism and Dynamic Regulation of Epithelial to Mesenchymal Transition in Ovarian Cancer

  2023cites this paper
• The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models.

  2023cites this paper
• Mesenchymal ovarian cancer cells promote CD8+ T cell exhaustion through the LGALS3-LAG3 axis

  2023cites this paper
• Snail transcription factors as key regulators of chemoresistance, stemness and metastasis of ovarian cancer cells.

  2023cites this paper
• Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches

  2023cites this paper
• Delta/Notch-like Epidermal Growth Factor-Related Receptor (DNER), a Potential Prognostic Marker of Gastric Cancer Regulates Cell Survival and Cell Cycle Progression

  2023cites this paper
• Nanomechanical Characterization of Ovarian Cancer Cell Lines as a Marker of Response to 2c Treatment

  2023cites this paper
• Emerging roles of endoplasmic reticulum stress in the cellular plasticity of cancer cells

  2023cites this paper
• Three-Dimensional Modelling of Ovarian Cancer: From Cell Lines to Organoids for Discovery and Personalized Medicine

  2022cites this paper
• The Development of a Three-Dimensional Platform for Patient-Derived Ovarian Cancer Tissue Models: A Systematic Literature Review

  2022influential citation
• Friend and foe: the regulation network of ascites components in ovarian cancer progression

  2022cites this paper
• Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites

  2022cites this paper
• Everolimus combined with 5-aza-2-deoxycytidine generated potent anti-tumor effects on ovarian clear cell cancer stem-like/spheroid cells by inhibiting the COL6A3-AKT-mTOR pathway.

  2022cites this paper
• The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination

  2022cites this paper
• Better or worse? The prognostic role of the mesenchymal subtype in patients with high‐grade serous ovarian carcinoma: A systematic review and meta‐analysis

  2022cites this paper
• Principles of dormancy evident in high-grade serous ovarian cancer

  2022cites this paper
• Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment.

  2022cites this paper
• A Systematic Comparative Assessment of the Response of Ovarian Cancer Cells to the Chemotherapeutic Cisplatin in 3D Models of Various Structural and Biochemical Configurations—Does One Model Type Fit All?

  2022cites this paper
• Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells

  2022cites this paper
• Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review

  2021cites this paper
• EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway

  2021cites this paper
• The Cancer Stem Cell Niche in Ovarian Cancer and Its Impact on Immune Surveillance

  2021cites this paper
• SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer.

  2021cites this paper
• The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence

  2021cites this paper
• Expression of Transforming Growth Factor Beta-1 and Its Correlation with Clinicopathologic Features of Ovarian Epithelial Carcinoma

  2021cites this paper
• Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes

  2021cites this paper
• Probing TGF-β1-induced cytoskeletal rearrangement by fluorescent-labeled silica nanoparticle uptake assay

  2021cites this paper
• The Hallmarks of Ovarian Cancer: Actionable Genetics, Targetable Pathways, and Predictive Biomarkers

  2021cites this paper
• Investigation of β5 integrin function in epithelial ovarian cancer cell adhesion and metastatic properties of spheroids

  2021cites this paper
• Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of Ovarian Carcinoma Cells

  2021cites this paper
• Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation

  2021cites this paper
• Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium

  2021cites this paper
• L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population

  2020cites this paper
• Eukaryotic Initiation Factor 5A2 (EIF5A2) Contributes to Ovarian Tumor Growth and Metastasis

  2020cites this paper
• The Role of microRNAs in Epithelial Ovarian Cancer Metastasis

  2020cites this paper
• Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium

  2020cites this paper
• Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive system.

  2020cites this paper
• A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids

  2020cites this paper
• Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy

  2020cites this paper
• The untapped potential of ascites in ovarian cancer research and treatment

  2020cites this paper
• Novel Therapeutic Strategies for Ovarian Cancer Stem Cells

  2020cites this paper
• Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids

  2020cites this paper
• Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems

  2020cites this paper
• Programmed Death-1 Receptor (PD-1) as a Potential Prognosis Biomarker for Ovarian Cancer Patients

  2020cites this paper
• Application of three dimensional (3D) tumor cell culture systems and mechanism of drug resistance.

  2019cites this paper
• The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance

  2019cites this paper
• Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas

  2019cites this paper
• MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2

  2019cites this paper
• Phenotypic Plasticity and the Origins and Progression of Ovarian Cancer

  2019cites this paper
• The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells

  2019cites this paper
• Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance

  2019cites this paper
• Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.

  2019cites this paper
• Blockade of TGF-β signaling with novel synthetic antibodies limits immune exclusion and improves chemotherapy response in metastatic ovarian cancer models

  2018cites this paper
• 3D Co-culture System of Tumor-associated Macrophages and Ovarian Cancer Cells.

  2018cites this paper
• Paeoniflorin Inhibits Migration and Invasion of Human Glioblastoma Cells via Suppression Transforming Growth Factor β-Induced Epithelial–Mesenchymal Transition

  2018cites this paper
• miR-532-5p is a prognostic marker and suppresses cells proliferation and invasion by targeting TWIST1 in epithelial ovarian cancer.

  2018cites this paper
• Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities

  2018cites this paper
• Role of tumor microenvironment in ovarian cancer pathobiology

  2018cites this paper
• Halfway between 2D and Animal Models: Are 3D Cultures the Ideal Tool to Study Cancer-Microenvironment Interactions?

  2018cites this paper
• c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer

  2017cites this paper
• EMT/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids

  2017cites this paper
• PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state

  2017cites this paper
• Activin B Regulates Adhesion, Invasiveness, and Migratory Activities in Oral Cancer: a Potential Biomarker for Metastasis

  2017influential citation
• ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis.

  2017cites this paper
• Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner

  2017cites this paper
• Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer

  2017influential citation
• Ascitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment

  2017cites this paper
• The impact on high‐grade serous ovarian cancer of obesity and lipid metabolism‐related gene expression patterns: the underestimated driving force affecting prognosis

  2017influential citation
• ASK 1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis

  2017cites this paper
• Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling.

  2017cites this paper
• Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3

  2016cites this paper
• Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway*

  2016cites this paper
• Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.

  2016cites this paper
• Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions

  2016cites this paper
• Impact of the ovarian microenvironment on serous cancer

  2016cites this paper